NCT02954302

Brief Summary

This study aims to evaluate whether the incidence of delayed gastric emptying (DGE) can be reduced by proximal Roux-en-y gastrojejunal anastomosis in comparison with the standard gastrojejunal anastomosis in pylorus-resecting pancreaticoduodenectomy (PrPD).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
140

participants targeted

Target at P50-P75 for not_applicable pancreatic-cancer

Timeline
Completed

Started Sep 2016

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2016

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

September 7, 2016

Completed
2 months until next milestone

First Posted

Study publicly available on registry

November 3, 2016

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2018

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2018

Completed
Last Updated

November 3, 2016

Status Verified

November 1, 2016

Enrollment Period

2.2 years

First QC Date

September 7, 2016

Last Update Submit

November 1, 2016

Conditions

Keywords

Delayed gastric emptyingpancreaticoduodenectomy

Outcome Measures

Primary Outcomes (1)

  • Delayed gastric emptying,rate

    The severity of DGE was classified into 3 grades (A, B, or C) according to the ISGPS's clinical criteria, based on the patient's clinical course and postoperative management, such as the need for NGT in the postoperative period or the inability to tolerate solid oral intake. Grade A was defined as needing the NGT for more than 7 days or reinsertion of the NGT after postoperative day 3, or as being unable to tolerate a solid diet by postoperative day 7. Grade B was defined as needing for NGT for 8 to 14 days after surgery or reinsertion of the NGT after day 7, or as being unable to tolerate a solid diet by postoperative day 14. Grade C was defined as needing the NGT for more than 14 days or reinsertion of the NGT after day 14, or as being unable to tolerate a solid diet by day 21.

    60 days after operation

Secondary Outcomes (8)

  • Morbidity,rate

    60 days after operation

  • Mortality,rate

    60 days after operation

  • Length of hospital stay,days

    60 days after operation

  • Pancreatic fistula,rate

    60 days after operation

  • Hemorrhage,rate

    60 days after operation

  • +3 more secondary outcomes

Other Outcomes (1)

  • nonsurgical complications,rate

    60 days after operation

Study Arms (2)

PrPD with RGA

EXPERIMENTAL

Patients who will undergo PrPD with proximal Roux-en-y gastrojejunal anastomosis.

Procedure: PrPD with proximal Roux-en-y gastrojejunal anastomosis

conventional PrPD

EXPERIMENTAL

Patients who will undergo conventional PrPD.

Procedure: conventional PrPD

Interventions

the distal antrum was divided about 1 to 2 cm proximal to the pylorus ring, preserving more than 95% of the stomach. The proximal jejunum was divided approximately 2 to 4 cm distal to the duodeno-jejunal junction. After completion of the resection, the proximal end of the first loop of jejunum was then brought through the transverse mesocolon, and the gastrojejunal anastomosis (GJA) was performed in two layers by using 3-0 PDS sutures and 4-0 silk sutures in an end-to-side fashion. The jejunum was then divided 35 to 40 cm distal to the GJA, and the distal limb was brought separately through the transverse mesocolon to be placed in the duodenal bed for reconstruction of the pancreatojejunal anastomosis (PJA) and hepatojejunal anastomosis (HJA).

PrPD with RGA

After completion of the pancreatojejunal anastomosis (PJA) and hepatojejunal anastomosis (HJA), a hand-sewn, isoperistaltic GJA was performed 25 to 30 cm distal to the HJA in two layers by using 3-0 polydioxanone (PDS) sutures and 4-0 silk sutures.

conventional PrPD

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who were scheduled to undergo PD and provided written informed consent.
  • In the opinion of the surgeon, the subject has no medical contraindications to PD.
  • At least 18 years of age.

You may not qualify if:

  • Patients who underwent other surgical procedures than PD, such as total pancreatectomy (TP) or a palliative biliary and gastroenteric anastomosis.
  • Drug abusers or alcoholics.
  • Patient who have previous transabdominal surgery.
  • The patient who were scheduled to undergo laparoscopic PD.
  • The patient who does not want to participate the clinical trials.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

First affiliated Hospital of Xiamen University

Xiamen, Fujian, 361003, China

RECRUITING

Related Publications (1)

  • Barakat O, Cagigas MN, Bozorgui S, Ozaki CF, Wood RP. Proximal Roux-en-y Gastrojejunal Anastomosis with Pyloric Ring Resection Improves Gastric Emptying After Pancreaticoduodenectomy. J Gastrointest Surg. 2016 May;20(5):914-23. doi: 10.1007/s11605-016-3091-5. Epub 2016 Feb 5.

MeSH Terms

Conditions

Pancreatic NeoplasmsBile Duct NeoplasmsDuodenal NeoplasmsGastroparesis

Condition Hierarchy (Ancestors)

Digestive System NeoplasmsNeoplasms by SiteNeoplasmsEndocrine Gland NeoplasmsDigestive System DiseasesPancreatic DiseasesEndocrine System DiseasesBiliary Tract NeoplasmsBile Duct DiseasesBiliary Tract DiseasesIntestinal NeoplasmsGastrointestinal NeoplasmsGastrointestinal DiseasesDuodenal DiseasesIntestinal DiseasesStomach DiseasesParalysisNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Yanming Zhou, Dr

    First affiliated Hospital of Xiamen University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mingqiang Lin, Dr

CONTACT

Yanming Zhou, Dr

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 7, 2016

First Posted

November 3, 2016

Study Start

September 1, 2016

Primary Completion

November 1, 2018

Study Completion

December 1, 2018

Last Updated

November 3, 2016

Record last verified: 2016-11

Data Sharing

IPD Sharing
Will not share

There is no plan to make individual participant data.

Locations